Epidemiologic critique of literature on post-transplant neoplasms in solid organ transplantation

Clinical Transplantation

Volumn 23, Issue 5, 2009, Pages 582-588

  Lanza, Lee L ^a   Wang, Lili ^b   Simon, Teresa A ^c   Irish, William D ^d  

^a RTI HEALTH SOLUTIONS   (United States)

^b SANOFI   (France)

^c BRISTOL MYERS SQUIBB   (United States)

^d CTI   (United States)

Author keywords

Epidemiology; Outcomes; Post transplantation neoplasia

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER RISK; EPIDEMIC; EPIDEMIOLOGICAL DATA; HEART TRANSPLANTATION; HUMAN; INCIDENTAL FINDING; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALIGNANT NEOPLASTIC DISEASE; NEOPLASM; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; SKIN CANCER;

FOLLOW-UP STUDIES; HUMANS; NEOPLASMS; ORGAN TRANSPLANTATION; PUBLICATIONS; RISK FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 70350166795     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2009.01061.x     Document Type: Article

References (71)

1. 2005 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1995-2004 2005, Rockville, MD, Health and Human Services Administration, Healthcare Systems Bureau, Division of Transplantation
2. Merion RM. The 2004 SRTR report on the state of transplantation. Am J Transplant 2006, 6:1093.
3. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000, 42:605.
4. Penn I, Hammond W, Brettschneider L, Starzl TE. Malignant lymphomas in transplantation patients. Transplant Proc 1969, 1:106.
5. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant 2004, 4:905.
6. Ippoliti G, Rinaldi M, Pellegrini C, Vigano M. Incidence of cancer after immunsuppressive treatment for heart transplantation. Crit Rev Oncol Hematol 2005, 56:101.
7. Adami J, Gabel H, Lindelof B. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 2003, 89:1221.
8. Agraharkar ML, Cinclair RD, Kuo YF, Daller JA, Shahinian VB. Risk of malignancy with long-term immunosuppression in renal transplant recipients. Kidney Int 2004, 66:383.
9. Ahmed Z, Marshall MB, Kucharczuk JC, Kaiser LR, Shrager JB. Lung cancer in transplant recipients. A single-institution experience. Arch Surg 2004, 139:902.
10. Bates WD, Gray DW, Dada MA. Lymphoproliferative disorders in Oxford renal transplant recipients. J Clin Pathol 2003, 56:439.
11. Bavinck JN, Hardie DR, Green A. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation 1996, 61:715.
12. Berber I, Altaca G, Aydin C. Kaposi's sarcoma in renal transplant patients: predisposing factors and prognosis. Transplant Proc 2005, 37:967.
13. Birkeland SA, Lokkegaard H, Storm HH. Cancer risk in patients on dialysis and after renal transplantation. Lancet 2000, 355:1886.
14. Boeckle E, Boesmueller C, Wiesmayr S. Kaposi sarcoma in solid organ transplant recipients: a single center report. Transplant Proc 2005, 37:1905.
15. Brann WM, Bennett LE, Keck BM, Hosenpud JD. Morbidity, functional status, and immunosuppressive therapy after heart transplantation: an analysis of the joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry. J Heart Lung Transplant 1998, 17:374.
16. Caforio AL, Fortina AB, Piaserico S. Skin cancer in heart transplant recipients: risk factor analysis and relevance of immunosuppressive therapy. Circulation 2000, 102:III222.
17. Caillard S, Dharnidharka V, Agodoa L, Bohen E, Abbott K. Post-transplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplantation 2005, 80:1233.
18. Cherikh WS, Kauffman HM, McBride MA, Maghirang J, Swinnen LJ, Hanto DW. Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation. Transplantation 2003, 76:1289.
19. Danpanich E, Kasiske BL. Risk factors for cancer in renal transplant recipients. Transplantation 1999, 68:1859.
20. Domingo-Domenech E, de Sanjose S, Gonzalez-Barca E. Post-transplant lymphomas: a 20-year epidemiologic, clinical and pathologic study in a single center. Haematologica 2001, 86:715.
21. Edwards LB, Keck BM. Thoracic organ transplantation in the US. Clin Transpl 2002, 29:29.
22. Faull RJ, Hollett P, McDonald SP. Lymphoproliferative disease after renal transplantation in Australia and New Zealand. Transplantation 2005, 80:193.
23. Formicone F, Fargnoli MC, Pisani F, Rascente M, Famulari A, Peris K. Cutaneous manifestations in Italian kidney transplant recipients. Transplant Proc 2005, 37:2527.
24. Gjersvik P, Hansen S, Moller B. Are heart transplant recipients more likely to develop skin cancer than kidney transplant recipients?. Transpl Int 2000, 13(Suppl 1):S380.
25. Haagsma EB, Hagens VE, Schaapveld M. Increased cancer risk after liver transplantation: a population-based study. J Hepatol 2001, 34:84.
26. Harden PN, Fryer AA, Reece S, Smith AG, Ramsay HM. Annual incidence and predicted risk of nonmelanoma skin cancer in renal transplant recipients. Transplant Proc 2001, 33:1302.
27. Herrero JI, Lorenzo M, Quiroga J. De novo neoplasia after liver transplantation: an analysis of risk factors and influence on survival. Liver Transpl 2005, 11:89.
28. Hollenbeak CS, Todd MM, Billingsley EM, Harper G, Dyer AM, Lengerich EJ. Increased incidence of melanoma in renal transplantation recipients. Cancer 2005, 104:1962.
29. Jain AB, Yee LD, Nalesnik MA. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation 1998, 66.
30. Kahan BD, Yakupoglu YK, Schoenberg L. Low incidence of malignancy among sirolimus/cyclosproine-treated renal transplant recipients. Transplantation 2005, 80:749.
31. Kasiske BL, Danpanich E. Malignancies in renal transplant recipients. Transplant Proc 2000, 32:1499.
32. Kyllonen L, Salmela K, Pukkala E. Cancer incidence in a kidney-transplanted population. Transpl Int 2000, 13(Suppl 1):S394.
33. Lemoine A, Pham P, Azoulay D. Detection of gammopathy by serum protein electrophoresis for predicting and managing therapy of lymphoproliferative disorder in 911 recipients of liver transplants. Blood 2001, 98:1332.
34. Levine SM, Angel L, Anzueto A. A low incidence of posttransplant lymphoproliferative disorder in 109 lung transplant recipients. Chest 1999, 116:1273.
35. Libertiny G, Watson CJ, Gray DW, Welsh KI, Morris PJ. Rising incidence of post-transplant lymphoproliferative disease in kidney transplant recipients. Br J Surg 2001, 88:1330.
36. Lindelof B, Dal H, Wolk K, Malmborg N. Cutaneous squamous cell carcinoma in organ transplant recipients. Arch Dermatol 2005, 141:447.
37. London NJ, Farmery SM, Lodge JPA, Will EJ, Davidson AM. Risk of neoplasia in renal transplant patients. Lancet 1995, 346:403.
38. Marcen R, Pascual J, Tato AM. Influence of immunosuppression on the prevalence of cancer after kidney transplantation. Transplant Proc 2003, 35:1714.
39. Mithoefer AB, Supran S, Freeman RB. Risk factors associated with the development of skin cancer after liver transplantation. Liver Transpl 2002, 8:939.
40. Mitxelena J, Gomez-Ullate P, Aguirre A, Rubio G, Lampreabe I, Diaz-Perez JL. Kaposi's sarcoma in renal transplant patients: experience at the Cruces Hospital in Bilbao. Int J Dermatol 2003, 42:18.
41. Molmenti EP, Molmenti H, Weinstein J. Syndromic incidence of ovarian carcinoma after liver transplantation, with special reference to anteceding breast cancer. Dig Dis Sci 2003, 48:187.
42. Moosa MR. Kaposi's sarcoma in kidney transplant recipients: a 23-year experience. Q J Med 2005, 98:205.
43. Moray G, Basaran O, Yagmurdur MC, Emiroglu R, Bilgin N, Haberal M. Immunosuppressive therapy and Kaposi's sarcoma after kidney transplantation. Transplant Proc 2004, 36:168.
44. Muti G, De Gasperi A, Cantoni S. Incidence and clinical characteristics of posttransplant lymphoproliferative disorders: report from a single center. Transpl Int 2000, 13(Suppl 1):S382.
45. Nemes B, Zalatnai A, Podder H. Papillary microcarcinoma of the thyroid gland in renal transplant patients. Pathol Oncol Res 2000, 6:72.
46. Neuzillet Y, Lay F, Luccioni A. De novo renal cell carcinoma of native kidney in renal transplant recipients. Cancer 2005, 103:251.
47. Ong CS, Keogh AM, Kossard S, Macdonald PS, Spratt PM. Skin cancer in Australian heart transplant recipients. J Am Acad Dermatol 1999, 40:27.
48. Oo YH, Gunson BK, Lancashire RJ, Cheng KK, Neuberger JM. Incidence of cancers following orthotopic liver transplantation ina single center: comparison with national cancer incidence rates for England and Wales. Transplantation 2005, 80:759.
49. Pedotti P, Cardillo M, Rossini G. Incidence of cancer after kidney transplant: results from the North Italy transplant program. Transplantation 2003, 76:1448.
50. Peraira JR, Segovia J, Fuertes B. Current induction immunosuppression and post-heart transplant lymphoproliferative disorders. Transplant Proc 2003, 35:2009.
51. Pollard JD, Hanasono MM, Mikulec AA, Le QT, Terris DJ. Head and neck cancer in cardiothoracic transplant recipients. Laryngoscope 2000, 110:1257.
52. Pond F, Serpell JW, Webster A. Thyroid cancer in the renal transplant populaiton: epidemiological study. ANZ J Surg 2005, 75:106.
53. Potaris K, Radovancevic B, Thomas CD. Lung cancer after heart transplantation: a 17-year experience. Ann Thoracic Surg 2005, 79:980.
54. Preciado DA, Matas A, Adams GL. Squamous cell carcinoma of the head and neck in solid organ transplant recipients. Head Neck 2002, 24:319.
55. Pruthi J, Medkiff KA, Esrason KT. Analysis of causes of death in liver transplant recipients who survived more than 3 years. Liver Transpl 2001, 7:811.
56. Ramalingam P, Rybicki L, Smith MD. Posttransplant lymphoproliferative disorders in lung transplant patients: the Cleveland Clinic experience. Mod Pathol 2002, 15:647.
57. Ramsay HM, Fryer AA, Hawley CM, Smith AG, Nicol DL, Harden PN. Factors associated with nonmelanoma skin cancer following renal transplantation in Queensland, Australia. J Am Acad Dermatol 2003, 49:397.
58. Rascente M, Pisani F, Barletta A. Malignancies after kidney transplantation. Transplant Proc 2005, 37:2529.
59. Reams BD, McAdams HP, Howell DN, Steele MP, Davis RD, Palmer SM. Posttransplant lymphoproliferative disorder: incidence, presentation, and response to treatment in lung transplant recipients. Chest 2003, 124:1242.
60. Saidi RF, Dudrick PS, Goldman MH. Colorectal cancer after renal transplantation. Transplant Proc 2003, 35:1410.
61. Saigal S, Norris S, Muiesan P, Rela M, Heaton N, O'Grady J. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl 2002, 8:482.
62. Sanchez EQ, Marubashi S, Jung G. De novo tumors after liver transplantation: a single-institution experience. Liver Transpl 2002, 8:285.
63. Serraino D, Piselli P, Angeletti C. Risk of Kaposi's sarcoma and of other cancers in Italian renal transplant patients. Br J Cancer 2005, 92:572.
64. Sheiner P, Magliocca JF, Bodian CA. Long-term medical complications in patients surviving >= 5 years after liver transplant. Transplantation 2000, 69:781.
65. Snanoudj R, Kriaa F, Arzouk N. Single-center experience with cyclosporine therapy for kidney transplantation: analysis of a twenty-year period in 1200 patients. Transplant Proc 2004, 36(Suppl 2S):83S.
66. Soler MJ, Puig JM, Mir M. Posttransplant lymphoproliferative disease: treatment and outcome in renal transplant recipients. Transplant Proc 2003, 35:1709.
67. Tremblay F, Fernandes M, Habbab F, Edwardes MDD, Loertscher R, Meterissian S. Malignancy after renal transplantation: incidence and role of type of immunosuppression. Ann Surg Oncol 2002, 9:785.
68. Winkelhorst JT, Brokelman WJ, Tiggeler RG, Wobbes T. Incidence and clinical course of de-novo malignancies in renal allograft recipients. Eur J Surg Oncol 2001, 27:409.
69. Zavos G, Bokos J, Papaconstantinou I. Clinicopathological aspects of 18 Kaposi's sarcoma among 1055 Greek renal transplant recipients. Artif Organs 2004, 28:595.
70. Rothman KJ. Writing for epidemiology. Epidemiology 1998, 9:333.
71. Walker AM. Reporting the results of epidemiologic studies. AJPH 1986, 76:556.